Issue 82, 2014

Red fluorescent hybrid mesoporous organosilicas for simultaneous cell imaging and anticancer drug delivery

Abstract

A safranin–diurea bridged hybrid mesoporous organosilica (SDU–HMS) was synthesized for simultaneous diagnosis and therapy. This study assessed the impact of integrated functional units on drug loading/release and imaging. The drug delivery efficiency and biocompatibility of the red fluorescent SDU–HMS carrier was evaluated experimentally.

Graphical abstract: Red fluorescent hybrid mesoporous organosilicas for simultaneous cell imaging and anticancer drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
06 Aug 2014
Accepted
03 Sep 2014
First published
03 Sep 2014

RSC Adv., 2014,4, 43342-43345

Author version available

Red fluorescent hybrid mesoporous organosilicas for simultaneous cell imaging and anticancer drug delivery

M. S. Moorthy, H. Song, J. Bae, S. Kim and C. Ha, RSC Adv., 2014, 4, 43342 DOI: 10.1039/C4RA08204D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements